Viva Biotech Holdings (HKG:1873)
Hong Kong
· Delayed Price · Currency is HKD 1.670
-0.040 (-2.34%)
Apr 29, 2026, 4:08 PM HKT
Viva Biotech Holdings Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 3,526 | 3,799 | 1,817 | 2,249 | 3,352 | 9,045 | Upgrade
|
| Market Cap Growth | -4.62% | 109.02% | -19.19% | -32.91% | -62.94% | -48.29% | Upgrade
|
| Enterprise Value | 3,806 | 4,090 | 2,374 | 4,227 | 5,809 | 10,494 | Upgrade
|
| Last Close Price | 1.67 | 1.80 | 0.86 | 1.05 | 1.75 | 4.71 | Upgrade
|
| PE Ratio | 16.67 | 15.53 | 10.21 | - | - | 25.63 | Upgrade
|
| Forward PE | 8.95 | 5.15 | 5.15 | 5.15 | 5.17 | 10.88 | Upgrade
|
| PS Ratio | 1.83 | 1.97 | 0.86 | 0.95 | 1.25 | 3.50 | Upgrade
|
| PB Ratio | 0.79 | 0.85 | 0.45 | 0.55 | 0.82 | 1.88 | Upgrade
|
| P/TBV Ratio | 2.07 | 2.23 | 1.33 | 1.84 | 3.05 | 6.01 | Upgrade
|
| P/FCF Ratio | 28.52 | - | 9.32 | 10.43 | 21.69 | - | Upgrade
|
| P/OCF Ratio | 13.64 | - | 4.57 | 5.32 | 7.68 | 94.67 | Upgrade
|
| PEG Ratio | - | 0.81 | 0.81 | 0.81 | 0.81 | 0.81 | Upgrade
|
| EV/Sales Ratio | 1.98 | 2.13 | 1.12 | 1.78 | 2.16 | 4.06 | Upgrade
|
| EV/EBITDA Ratio | 8.55 | 9.27 | 5.16 | 9.81 | 11.78 | 23.11 | Upgrade
|
| EV/EBIT Ratio | 18.12 | 19.02 | 9.71 | 19.92 | 19.32 | 36.09 | Upgrade
|
| EV/FCF Ratio | 30.79 | - | 12.17 | 19.61 | 37.58 | - | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.33 | 0.34 | 0.52 | 0.78 | 0.68 | Upgrade
|
| Debt / EBITDA Ratio | 3.36 | 3.36 | 2.90 | 4.71 | 6.25 | 6.81 | Upgrade
|
| Debt / FCF Ratio | - | - | 7.01 | 9.72 | 20.65 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.06 | 0.06 | 0.09 | 0.24 | 0.60 | 0.47 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.61 | 0.61 | 0.79 | 2.22 | 4.91 | 5.01 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 1.87 | 4.43 | 15.68 | -3.80 | Upgrade
|
| Asset Turnover | 0.24 | 0.24 | 0.27 | 0.28 | 0.30 | 0.26 | Upgrade
|
| Inventory Turnover | 3.53 | 3.53 | 4.88 | 4.84 | 5.61 | 7.33 | Upgrade
|
| Quick Ratio | 1.22 | 1.22 | 1.26 | 1.03 | 0.44 | 1.44 | Upgrade
|
| Current Ratio | 1.51 | 1.51 | 1.67 | 1.32 | 0.73 | 2.14 | Upgrade
|
| Return on Equity (ROE) | 6.88% | 6.88% | 5.92% | -2.74% | -13.41% | 7.84% | Upgrade
|
| Return on Assets (ROA) | 1.70% | 1.70% | 1.98% | 1.57% | 2.08% | 1.83% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.85% | 3.89% | 3.96% | 3.74% | 4.62% | 4.04% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.30% | 3.30% | 3.90% | 3.30% | 5.10% | 3.30% | Upgrade
|
| Earnings Yield | 6.94% | 6.44% | 9.80% | -5.69% | -17.82% | 3.90% | Upgrade
|
| FCF Yield | 3.51% | - | 10.73% | 9.59% | 4.61% | -6.61% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 5.66% | Upgrade
|
| Buyback Yield / Dilution | 18.44% | 18.44% | -41.39% | -5.91% | 2.81% | -25.41% | Upgrade
|
| Total Shareholder Return | 18.44% | 18.44% | -41.39% | -5.91% | 2.81% | -25.41% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.